Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Zhong‐Nan Xu"'
Autor:
Jing-Hang Xu, Sa Wang, Da-Zhi Zhang, Yan-Yan Yu, Chong-Wen Si, Zheng Zeng, Zhong-Nan Xu, Jun Li, Qing Mao, Hong Tang, Ji-Fang Sheng, Xin-Yue Chen, Qin Ning, Guang-Feng Shi, Qing Xie, Xi-Quan Zhang, Jun Dai
Publikováno v:
World Journal of Clinical Cases. 10:10085-10096
Autor:
Jing‐Hang Xu, Ya‐Nan Fan, Yan‐Yan Yu, Chong‐Wen Si, Zheng Zeng, Zhong‐Nan Xu, Jun Li, Qing Mao, Da‐Zhi Zhang, Hong Tang, Ji‐Fang Sheng, Xin‐Yue Chen, Qin Ning, Guang‐Feng Shi, Qing Xie, Xi‐Quan Zhang, Jun Dai
Publikováno v:
Journal of Viral Hepatitis. 29:862-867
This study aimed to evaluate the efficacy and safety of entecavir(ETV) versus ETV maleate in Chinese patients with chronic hepatitis B(CHB). This was a randomized, double-blind, double-dummy, controlled, multicentre study. Patients were randomly assi
Autor:
Zujiang Yu, Zhong-Nan Xu, Xiaofan Chen, Yanyan Yu, Jia Shang, Jing-Hang Xu, Jun Li, Ling Wang, Jun Cheng, Wenhong Zhang, Hao Wang, Chong-Wen Si, Xinyue Chen, Zhiliang Gao, Qing Mao, Hong Tang, Shanming Wu, Qing Xie, Wei Zhao, Jun Dai, Yanan Fan
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Tenofovir disoproxil fumarate (TDF) is a prodrug of a nucleotide analogue. As an antiviral drug, TDF has been proposed in the first-line treatment of chronic hepatitis B (CHB). Qingzhong, a brand name of TDF, commercialized by Jiangsu Chia
Autor:
Jia Xu, Hong Zhang, Hong Chen, Xiaoxue Zhu, Zhong-Nan Xu, Dandan Huo, Haiyan Jia, Yanhua Ding, Junqi Niu
Publikováno v:
Journal of Hepatology. 73:S466
Autor:
Qing Xie, Zujiang Yu, Zhong-Nan Xu, Xinyue Chen, Hong Tang, Hao Wang, Yanyan Yu, Wei Zhao, Jun Cheng, Jing-Hang Xu, Jun Li, Rongyue Liang, Chong-Wen Si, Jia Shang, Ling Wang, Qing Mao, Sa Wang, Zhiliang Gao, Shanming Wu, Jun Dai, Wenhong Zhang
Publikováno v:
Medicine. 98:e16778
Background:Tenofovir disoproxil fumarate (TDF) has been widely recommended as a first-line antiviral agent to treat chronic hepatitis B (CHB). Qingzhong and Viread, formulations of TDF commercialized by Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd
Autor:
Aidong Wen, Min Song, Zhong-Nan Xu, Mengxiang Su, Hua Zhao, De-Zhu Sun, Xiao-Le Zhan, Taijun Hang, Ling Zhu, Xiao Gu
Publikováno v:
Journal of Chromatography B. :39-43
A sensitive and selective liquid chromatographic tandem mass spectrometric method was developed and validated for the determination of sinomenine in human plasma. Plasma samples were precipitated using methanol with metronidazole as internal standard
Autor:
Jing-hang, Xu, Yan-yan, Yu, Chong-wen, Si, Zheng, Zeng, Jun, Li, Qing, Mao, Da-zhi, Zhang, Hong, Tang, Ji-fang, Sheng, Xin-yue, Chen, Qin, Ning, Guang-feng, Shi, Qing, Xie, Xi-quan, Zhang, Jun, Dai, Zhong-nan, Xu
Publikováno v:
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 21(12)
To evaluate the efficacy and safety of entecavir maleate (ETV) versus ETV in Chinese patients with hepatitis B e antigen(HBeAg)-positive chronic hepatitis B(CHB).The patient population of this previously published randomized, double-blind, double-dum
Autor:
Aidong Wen, Lin Yang, Weiwei Zhang, Shuping Qiang, Yunjing Zhang, Taijun Hang, Zhi Yu, Zhong-Nan Xu
Publikováno v:
Journal of chromatographic science. 52(4)
A specific and sensitive liquid chromatography-electrospray ionization-tandem mass spectrometric method was developed for the quantification of imatinib and its primary metabolite N-desmethyl imatinib in human plasma. Protein precipitation with metha
Publikováno v:
Journal of ethnopharmacology. 147(1)
Ethnopharmocological relevance Geranium wilfordii Maxim has been extensively used in Chinese Herbal Medicine for treating gastrointestinal disorders, diarrhea and dysentery. In the current study we aimed to investigate the anti-Helicobacter pylori ac
Autor:
Hua, He, Zhong-nan, Xu, Da-chuan, Cai, Ning, Nai, Ning, Ling, Wei-qun, Zeng, Xiao-feng, Shi, You-rong, Zhao, Zhi, Zhou, Da-zhi, Zhang
Publikováno v:
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 17(4)
To analyze the spontaneous decline of HBV DNA in chronic hepatitis B patients in 12 weeks.Chronic hepatitis B patients not receiving antiviral treatment from 2003 to 2005 were divided into two groups according to the baseline value of ALT and TBil. S